On Jul 26, Macquarie submitted the Change Report to Ministry of Finance. The report shows that Macquarie decreased their holdings in $BrightPath Biotherapeutics.JP$, with their joint shareholding ratio down from 5.71% to 1.84%, below 5%.
Source: Edinet Announcement
What is the 5% shareholding reporting system?
Shareholders with holding ratio exceeding 5% must submit a Large Shareholding Report within five business days from that day. If the holding ratio increases or decreases by 1% or more after submitting a Large Shareholding Report, the holder must submit a Change Report within five business days from that day.